Hyperbilirubinemia in African American neonates: clinical issues and current challenges

Seminars in Fetal and Neonatal Medicine

Volumn 15, Issue 3, 2010, Pages 176-182

  Watchko, Jon F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Female heterozygote; G6PD deficiency; Kernicterus; Late preterm gestation; Neonatal jaundice

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

AFRICAN AMERICAN; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; FOLLOW UP; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOSITY; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; KERNICTERUS; NEWBORN; PARENT COUNSELING; PHOTOTHERAPY; PREMATURITY; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; UNITED STATES;

ADULT; AFRICAN AMERICANS; BILIRUBIN; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY;

EID: 77953479548     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.11.001     Document Type: Article

References (72)

1. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 (2004) 297-316
2. Maisels M.J., Bhutani V.K., Bogen D., Newman T.B., Stark A.R., and Watchko J.F. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation - an update with clarifications. Pediatrics 124 (2009) 1193-1198
3. Watchko J.F. Identification of neonates at risk for hazardous hyperbilirubinemia. Emerging clinical insights. Pediatr Clin North Am 56 (2009) 671-687
4. Bhutani V.K., Johnson L.H., Maisels M.J., et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 24 (2004) 650-662
5. Johnson L., Bhutani V.K., Karp K., Sivieri E.M., and Shapiro S.M. Clinical report from the pilot USA Kernicterus Registry (1992-2004). J Perinatol 29 (2009) S25-S45
6. Keren R., Luan X., Friedman S., et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 121 (2008) e170-e179
7. Newman T.B., Escobar G.J., Gonzales V.M., et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 104 (1999) 1198-1203
8. Newman T.B., Easterling J., Goldman E.S., et al. Laboratory evaluation of jaundice in newborns. Frequency, cost and yield. Am J Dis Child 144 (1990) 364-368
9. Chou S.C., Palmer R.H., Ezhuthachan S., et al. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics 112 (2003) 1264-1273
10. Brown A.K., Kim M.H., Wu P.Y.K., and Bryla D.A. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 75 (1985) 393-441
11. Hardy J.B., Drage J.S., and Jackson E.E. The first year of life. The collaborative perinatal project of the National Institute of Neurological and Communicative Disorders and Stroke (1979), Johns Hopkins University Press, Baltimore p. 104
12. Linn S., Schoenbaum S.C., Monson R.R., Rosner B., Stubblefield P.G., and Ryan K.J. Epidemiology of neonatal hyperbilirubinemia. Pediatrics 75 (1985) 770-774
13. United States Census Bureau. 2006 American Community Survey.
14. Manning D., Todd P., Maxwell M., and Platt M.J. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 92 (2007) 342-346
15. Kaplan M., Herschel M., Hammerman C., Hoyer J.D., and Stevenson D.K. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 114 (2004) e213-e219
16. Kaplan M., Herschel M., Hammerman C., Hoyer J.D., Heller G.Z., and Stevenson D.K. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr 149 (2006) 83-88
17. Herschel M., Ryan M., Gelbart T., and Kaplan M. Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency. J Perinatol 22 (2002) 577-579
18. Kaplan M., and Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol 28 (2004) 356-364
19. Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency. Acta Paediatr Suppl 394 (1994) 58-76
20. Zangen S., Kidron D., Gelbart T., Roy-Chowdhury N., Wang X., and Kaplan M. Fatal kernicterus in a girl deficient in glucose-6-phophate dehydrogenase: a paradigm of synergistic heterozygosity. J Pediatr 154 (2009) 616-619
21. Washington E.C., Ector W., Abbound M., Ohning B., and Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a femal newborn. South Med J 88 (1995) 776-779
22. American Academy of Pediatrics. Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics 108 (2001) 763-765
23. Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event Alert: Kernicterus threatens healthy babies. Available at: (April 2001). http://www.JCAHO.org
24. Newman T.B., Kuzniewicz, Liljestrand P., Wi S., McCulloch C., and Escobar G.J. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics 123 (2009) 1352-1359
25. Newman T.B., Xiong B., Gonzales V.M., et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 (2000) 1140-1147
26. Newman T.B., Liljestrand P., and Escobar G.J. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 159 (2005) 113-119
27. Manolio T.A., Burke G.L., Savage P.J., et al. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 38 (1992) 1853-1859
28. Madhavan M., Wattigney W.A., Srinivasan S.R., and Berenson G.S. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 131 (1997) 107-113
29. Watchko J.F. Indirect hyperbilirubinemia in the neonate. In: Maisels M.J., and Watchko J.F. (Eds). Neonatal jaundice (2000), Harwood, Amsterdam 51-66
30. Stevenson D.K., Fanaroff A.A., Maisels M.J., et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 108 (2001) 31-39
31. Li R., Darling N., Maurice E., Barker L., and Grummer-Strawn L.M. Breastfeeding rates in the United States by characteristics of the child, mother, or family: the 2002 National Immunization Survey. Pediatrics 115 (2005) e31-e37
32. McDowell M.M., Wang C.Y., and Kennedy-Stephenson J. Breastfeeding in the United States: findings from the national health and nutrition examination surveys, 1999-2006. NCHS Data Brief 5 (2008) 1-8
33. Beutler E., Gelbert T., and Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism. Proc Natl Acad Sci U S A 95 (1998) 8170-8174
34. O'Flynn M.E., and Hsia D.Y. Serum bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in newborn American Negroes. J Pediatr 63 (1963) 160-161
35. Wolff J.A., Grossman B.H., and Paya K. Neonatal serum bilirubin and glucose-6-phosphate dehydrogenase. Am J Dis Child 113 (1967) 251-254
36. Zinkham W.H. Peripheral blood and bilirubin values in normal full term primaquine-sensitive Negro infants. Effect of vitamin K. Pediatrics 31 (1963) 983-995
37. Beutler E. G6PD deficiency. Blood 84 (1994) 3613-3636
38. Nkhoma E.T., Poole C., Vannappagari V., Hall S.A., and Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42 (2009) 267-278
39. Chinevere T.D., Murray C.K., Grant E., et al. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med 171 (2006) 905-907
40. Slusher T.M., Vreman H.J., McLaren D.W., Lewison L.J., Brown A.K., and Stevenson D.K. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 126 (1995) 102-108
41. Bosma P.J., Roy Chowdhury J., Bakker C., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333 (1995) 1171-1175
42. Bancroft J.D., Kreamer B., and Gourley G.R. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 132 (1998) 656-660
43. Monaghan G., McLellan A., McGeehan A., et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 134 (1999) 441-446
44. Maruo Y., Nishizawa K., Sato H., et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 103 (1999) 1224-1227
45. Kaplan M., Renbaum P., Levy-Lahad E., et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 94 (1997) 12128-12132
46. Bhutani V., Johnson L., Sivieri E.M., et al. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103 (1999) 6-14
47. Watchko J.F., Lin Z., Clark R.H., Kelleher A.S., Walker W., and Spitzer A.R. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics 124 (2009) e868-e877
48. Sugatani J., Yamakawa K., Yoshinari K., et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun 292 (2002) 492-497
49. Cui Y., Konig J., Leier I., et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276 (2001) 9626-9630
50. Briz O., Serrano M.A., MacIas R.I., et al. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J 371 (2000) 897-905
51. Lin Z., Fontaine J., and Watchko J.F. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics 122 (2008) e156-e162
52. Beutler E., and Baluda M.C. The separation of glucose-6-phosphate dehydrogenase deficient erythrocytes from the blood of heterozygotes for glucose-6-phosphate dehydrogenase deficiency. Lancet 1 (1964) 189-192
53. May J., Meyer C.G., Großterlinden L., et al. Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health 5 (2000) 119-123
54. Valaes T. Bilirubin distribution and dynamics of bilirubin removal by exchange transfusion. Acta Paediatr 52 Suppl. 149 (1963) 1-115
55. Beutler E., Dern R.J., and Alving A.S. The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med 44 (1954) 439-442
56. Kaplan M., Merob P., and Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 28 (2008) 389-397
57. Padilla C.D., and Therrell B.L. Newborn screening in the Asia Pacific region. J Inherit Metab Dis 30 (2007) 490-506
58. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111 (2008) 16-24
59. Watchko J.F. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin Perinatol 33 (2006) 839-852
60. Bhutani V.K., and Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 30 (2006) 89-97
61. Wang M.L., Dorer D.J., Fleming M.P., et al. Clinical outcomes of near-term infants. Pediatrics 114 (2004) 372-376
62. Neifert M.R. Prevention of breastfeeding tragedies. Pediatr Clin North Am 48 (2001) 273-297
63. Bucher K.A., Patterson A.M., Elston R.C., Jones C.A., and Kirkman H.N. Racial difference in incidence of ABO hemolytic disease. Am J Public Health 66 (1976) 854-858
64. Toy P.T.C.Y., Reid M.E., Papenfus L., Yeap H.H., and Black D. Prevalence of ABO maternal-infant incompatibility in Asians, Blacks, Hispanics, and Caucasians. Vox Sang 54 (1988) 181-183
65. Naiman J.L. Erythroblastosis fetalis. In: Oski F.A., and Naiman J.L. (Eds). Hematologic problems in the newborn (1982), WB Saunders, Philadelphia 326-332
66. Kirkman H.N. Further evidence for a racial difference in frequency of ABO hemolytic disease. J Pediatr 90 (1977) 717-721
67. Halbrecht I. Role of hemagglutinins anti-A and anti-B in pathogenesis of jaundice of the newborn (icterus neonatorum precox). Am J Dis Child 68 (1944) 248-249
68. Cashore W.J. Neonatal hyperbilirubinemia. In: Oski F.A., DeAngelis C.D., Feigin R.D., and Warshaw J.B. (Eds). Principles and practice of pediatrics (1990), JB Lippincott, Philadelphia 399-408
69. Davidson L.T., Merritt K.K., and Weech A.A. Hyperbilirubinemia in the newborn. Am J Dis Child 61 (1941) 958-980
70. Moyer V.A., Ahn C., and Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med 154 (2000) 391-394
71. Tayaba R., Gribetz D., Gribetz I., and Holzman I.R. Noninvasive estimation of serum bilirubin. Pediatrics 102 (1998) e28
72. Keren R., Tremont K., Luan X., et al. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed 94 (2009) F317-F322